Thrivent Financial For Lutherans Adma Biologics, Inc. Transaction History
Thrivent Financial For Lutherans
- $52.6 Billion
- Q3 2024
A detailed history of Thrivent Financial For Lutherans transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 190,205 shares of ADMA stock, worth $3.61 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
190,205Holding current value
$3.61 Million% of portfolio
0.01%Shares
5 transactions
Others Institutions Holding ADMA
# of Institutions
320Shares Held
185MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$354 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$344 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$247 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$240 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$163 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.73B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...